98%
921
2 minutes
20
Tocotrienols are members of the vitamin E family and exhibit antioxidant properties, immunomodulatory effects, and anti-inflammatory actions. Previously, we demonstrated that γ-tocotrienol inhibits human airway smooth muscle (ASM) cell proliferation, migration, contractile phenotype expression, and extracellular matrix protein synthesis by suppressing RhoA activation. In this study, we investigated whether α- or δ-tocotrienol modulates transforming growth factor-beta 1 (TGF-β1)-induced contractile phenotype expression in human ASM cells and platelet-derived growth factor-BB (PDGF-BB)-induced proliferation and migration of ASM cells. Human ASM cells were pretreated with α- or δ-tocotrienol before stimulation with PDGF-BB to promote proliferation and migration or with TGF-β1 to induce smooth muscle actin expression. PDGF-BB-stimulated ASM cell proliferation and migration were assessed using colorimetric and transwell migration assays. Additionally, we examined the signaling pathways involved in the effects of α- or δ-tocotrienol on PDGF-BB-induced ASM proliferation and migration, as well as TGF-β1-induced smooth muscle actin expression. TGF-β1 increased α-smooth muscle actin expression in human ASM cells. Treatment with α- and δ-tocotrienol slightly reduced α-smooth muscle actin levels, though this reduction was not statistically significant. In contrast, PDGF-BB-induced ASM cell proliferation and migration were significantly inhibited by α- and δ-tocotrienol treatment. The effects of α- and δ-tocotrienol on ASM proliferation and migration involve the RhoA signaling pathway and a reduction in reactive oxygen species (ROS) production. These findings suggest that α- and δ-tocotrienol exert beneficial effects on airway remodeling in asthma by inhibiting the proliferation and migration of human ASM cells.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3177/jnsv.71.300 | DOI Listing |
Turk J Pediatr
September 2025
Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
Background: Glucocorticoids remain the primary treatment for acute lymphoblastic leukemia (ALL) in children. However, glucocorticoid-resistant ALL exhibits increased mortality rates. To overcome resistance and improve management strategies, alternative therapeutic agents are required.
View Article and Find Full Text PDFPlant J
September 2025
State Key Laboratory of Plant Diversity and Specialty Crops, Wuhan Botanical Garden, Chinese Academy of Science, Wuhan, Hubei, 430074, China.
Trapa L. is a non-cereal aquatic crop with significant economic and ecological value. However, debates over its classification have caused uncertainties in species differentiation and the mechanisms of polyploid speciation.
View Article and Find Full Text PDFNeurology
October 2025
Neurology, Epilepsy and Movement Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies - EpiCARE, Rome, Italy.
Objectives: Neuronal ceroid lipofuscinosis type 3 (CLN3) is a rare lysosomal storage disorder characterized by progressive neurodegeneration. No disease-modifying treatments are currently available. Miglustat, a substrate reduction therapy, has shown preclinical efficacy in CLN3 models (conference abstract).
View Article and Find Full Text PDFJ Palliat Care
September 2025
Department of Healthcare Administration and Policy, School of Public Health, University of Nevada, Las Vegas, NV, USA.
ObjectivesRecently, atrial fibrillation (AF) has contributed to an increase in cardiovascular deaths in the U.S. Palliative care (PC) and atrial ablation (AA) procedure can elevate quality of life of high-risk AF patients, who are associated with multiple comorbidities.
View Article and Find Full Text PDFJ Oncol Pharm Pract
September 2025
Department of Clinical Haematology, National Institute of Blood Disease and Bone Marrow Transplantation, Karachi City, Sindh, Pakistan.
IntroductionConditioning regimen-related hepatotoxicity is one of the frequent causes of morbidity and mortality in hematological disorder patients undergoing bone marrow transplantation-the current study aimed to evaluate the effects of conditioning regimens on liver enzymes.MethodsThis observational analytical study was conducted for one year and recruited patients who received conditioning regimens before undergoing Bone Marrow Transplantation for benign hematological disorder [aplastic anemia (AA) and beta-thalassemia major (BTM)]. Pre-and post-transplant assessment particularly liver function test was done.
View Article and Find Full Text PDF